Biotech crops fall from favor as seed firms prune launches
Washington reports biotech crop developers have fewer new varieties due to weak farm economy and public resistance. In 1999 six applications sought approval, the fewest since 1993, with four withdrawals by year end. Only one filed this year. By contrast 1997 saw 14 and 1998 saw nine approvals, with four denials. Analyst Alex Hittle warns stock prices suffer when pursuing biotech approvals.
MENTIONED IN THIS ARTICLE
Washington
Agriculture Department
Alex Hittle
A.G. Edwards and Sons Inc
USDA
Pioneer and
Dow Chemical Co
DNA Plant Technology
Monsanto
Daniel Verakis
Biotech crop approvals show slow year amid industry lull
Government records trace annual GE crop applications from 1992 to 2000, with fluctuations from two to sixteen filings. Industry officials say the slowdown reflects a natural lull near the end of the first development wave, while investors grow wary and some firms pivot toward pharmaceuticals.
MENTIONED IN THIS ARTICLE
Bred International Inc
Wall Street
Novartis
AstraZeneca
St. Louis
Monsanto Co
Pharmacia & Upjohn Corp
Monsanto
Biotech Food
Europe
Asia
United States
Indus
Also Mentioned on This Page
Wall St
Michael Phillips
Food and Agriculture
The
Biotechnology Industry Organization
Doyle Karr
Pioneer Hi
Frito-Lay Inc
Environmental Protection Agency
Se OO